Burden of Visual Impairment Has Increased Globally
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Dec. 12, 2023 -- The number of prevalent cases of visual impairment globally increased substantially in working-age individuals from 1990 to 2019, according to a study published online Dec. 7 in JAMA Ophthalmology.
Jianqi Chen, M.D., from the Zhongshan Ophthalmic Center at Sun Yat-sen University in Guangzhou, China, and colleagues investigated the trends of visual impairment prevalence and disability-adjusted life-years (DALYs) in working-age (15 to 64 years) individuals (1990 to 2019). The analysis included data from 204 countries and territories participating in the Global Burden of Disease 2019 study.
The researchers identified 437.5 million prevalent cases of visual impairment globally (53.12 percent female) in 2019, representing an increase of 91.46 percent from 1990 (prevalent cases, 228.5 million). Visual impairment-associated DALYs increased over three decades from 7.6 million to 12.6 million. The low sociodemographic index group had the largest increase in DALYs (898,167 in 1990 to 1.6 million in 2019). The greatest increase in prevalence was seen in Eastern Europe. Overall, Nepal had the highest national prevalence of visual impairment (26,008 per 100,000 population in 2019), while South Sudan had the highest DALY rate (480.59 per 100,000 population).
"The correlation between visual impairment in working-age individuals and their personal well-being and socioeconomic productivity necessitates further research and prompts development of efficient strategies aimed at alleviating the burden of visual impairment," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-13 22:15
Read more
- When This Black Cat Crossed His Path, It Was a Lucky Day for Medicine
- Urban Green Space May Protect Against Heat-Related Health Risks
- Mpox Spread in Congo May Be Slowing
- In-Utero Sugar Restriction Cuts Offspring's Risk for Diabetes, Hypertension
- FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine
- ACAAI: 2013 to 2023 Saw Rise in Pediatric Psych Referrals Tied to Food Allergies
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions